Accès gratuit
Numéro
Med Sci (Paris)
Volume 22, Numéro 6-7, Juin-Juillet 2006
Page(s) 595 - 600
Section M/S revues
DOI https://doi.org/10.1051/medsci/20062267595
Publié en ligne 15 juin 2006
  1. Ciba Guest Symposium. Terminology, definition and classification of chronic pulmonary emphysema and related conditions. Thorax 1959; 14 : 286–99.
  2. American Thoracic Society. Chronic bronchitis, asthma, and pulmonary emphysema. Statement by the committee on diagnostic standards for nontuberculous respiratory diseases. Am Rev Respir Dis 1962; 85 : 762–8.
  3. Barnes PJ, Drazen JM. Pathophysiology of asthma. In : Barnes PJ, Drazen JM, Rennard S, Thomson NC, eds. Asthma and COPD. Amsterdam : Academic Press, 2002 : 343–59.
  4. Elston WJ, Whittaker AJ, Khan LN, et al. Safety of research bronchoscopy, biopsy and bronchoalveolar lavage in asthma. Eur Respir J 2004; 24 : 375–7.
  5. Pizzichini E, Pizzichini MMM, Efthimiadis A, et al. Indices of airway inflammation in induced sputum : reproducibility and validity of cell and fluid-phase measurements. Am J Respir Crit Care Med 1996; 154 : 308–17.
  6. Fahy JV. A safe, simple, standardized method should be used for sputum induction for research purposes. Clin Exp Allergy 1998; 28 : 1047–9.
  7. Green RH, Brighting CE, McKenna S, et al. Asthma exacerbations and sputum eosinophil counts : a randomised controlled trial. Lancet 2002; 360 : 1715–21.
  8. Wechsler ME, Grasemann H, Deykin A, et al. Exhaled nitric oxide in patients with asthma. Am J Respir Crit Care Med 2000; 162 : 2043–7.
  9. Piipari R, Piirila P, Keskinen H, et al. Exhaled nitric oxide in specific challenge tests to assess occupational asthma. Eur Respir J 2002; 20 : 1532–7.
  10. Maestrelli P, Saetta M, Di Stefano A, et al. Comparison of leukocyte counts in sputum, bronchial biopsies, and bronchoalveolar lavage. Am J Respir Crit Care Med 1995; 152 : 1926–31.
  11. Belda J, Leigh R, Parameswaran K, et al. Induced sputum cell counts in healthy adults. Am J Respir Crit Care Med 2000; 161 : 475–8.
  12. Efthimiadis A, Jayaram L, Weston S, et al. Induced sputum : time from expectoration to processing. Eur Respir J 2002; 19 : 706–8.
  13. Chan-Yeung M, Malo JL. Occupational asthma. N Engl J Med 1995; 333 : 107–12.
  14. Bernstein IL, Chan-Yeung M, Malo JL, Berstein DI. Asthma in the workplace, 3rd ed. New York : Francis and Taylor, 2006.
  15. Obata H, Cittrick M, Chan H, Chan-Yeung M. Sputum eosinophils and exhaled nitric oxide during late asthmatic reaction in patients with western red cedar asthma. Eur Respir J 1999; 13 : 489–95.
  16. Lemière C, Pizzichini MMM, Balkissoon R, et al. Diagnosing occupational asthma : use of induced sputum. Eur Respir J 1999; 13 : 482–8.
  17. Lemière C, Chaboillez S, Malo JL, Cartier A. Changes in sputum cell counts after exposure to occupational agents : What do they mean ? J Allergy Clin Immunol 2001; 107 : 1063–8.
  18. DiStefano F, DiGiampaolo L, Verna N, DiGioacchino M. Occupational eosinophilic bronchitis in a foundry worker exposed to isocyanate and a baker exposed to flour. Thorax 2006 (sous presse).
  19. Alvarez MJ, Castillo R, Rey A, et al. Occupational asthma in a grain worker due to Lepidoglyphus destructor, assessed by bronchial provocation test and induced sputum. Allergy 1999; 54 : 884–9.
  20. Maestrelli P, Calcagni PG, Saetta M, et al. Sputum eosinophilia after asthmatic responses induced by isocyanates in sensitized subjects. Clin Exp Allergy 1994; 24 : 29–34.
  21. Yacoub MR, Malo JL, Labrecque M, et al. Occupational eosinophilic bronchitis. Allergy 2005; 60 : 1542–4.
  22. Park HS, Jung KS, Kim HY, et al. Neutrophil activation following TDI bronchial challenges to the airway secretion from subjects with TDI-induced asthma. Clin Exp Allergy 1999; 29 : 1395–401.
  23. Lemière C, Romeo P, Chaboillez S, et al. Airway inflammation and functional changes after exposure to different concentrations of isocyanates. J Allergy Clin Immunol 2002; 110 : 641–6.
  24. Park HS, Jung KS, Hwang SC, et al. Neutrophil infiltration and release of IL-8 in airway mucosa from subjects with grain dust-induced occupational asthma. Clin Exp Allergy 1998; 28 : 724–30.
  25. Douwes J, Gibson P, Pekkanen J, Pearce N. Non-eosinophilic asthma : importance and possible mechanisms. Thorax 2002; 57 : 643–8.
  26. Lemière C, Chaboilliez S, Trudeau C, et al. Characterization of airway inflammation after repeated exposures to occupational agents. J Allergy Clin Immunol 2000; 106 : 1163–70.
  27. Girard F, Chaboillez S, Cartier A, et al. An effective strategy for diagnosing occupational asthma. Induced sputum. Am J Respir Crit Care Med 2004; 170 : 845–50.
  28. Anees W, Huggins V, Pavord ID, et al. Occupational asthma due to low molecular weight agents : eosinophilic and non-eosinophilic variants. Thorax 2002; 57 : 231–6.
  29. Leigh R, Hargreave FE. Occupational neutrophilic asthma. Can Respir J 1999; 6 : 194–6.
  30. Park HS, Kim HA, Jung JW, et al. Metalloproteinase-9 is increased after toluene diisocyanate exposure in the induced sputum from patients with toluene diisocyanate-induced asthma. Clin Exp Allergy 2003; 33 : 113–8.
  31. Krakowiak A, Krawczyk-Adamus P, Dudek W, et al. Changes in cellular and biochemical profiles of induced sputum after allergen-induced asthmatic response : method for studying occupational allergic airway inflammation. Int J Occup Med Environ Health 2005; 18 : 27–33.
  32. Bernstein IL, Keskinen H, Blanc PD, et al. Medicolegal aspects, compensation aspects, evaluation of impairment/disability. In : Bernstein IL, Chan-Yeung M, Bernstein DI, Malo Jl, eds. Asthma in the workplace, 3rd ed. New York : Francis and Taylor, 2006 : 319–51.
  33. Maghni K, Lemière C, Ghezzo H, et al. Airway inflammation after cessation of exposure to agents causing occupational asthma. Am J Respir Crit Care Med 2004; 169 : 367–72.
  34. Chan-Yeung M, Obata H, Dittrick M, et al. Airway inflammation, exhaled nitric oxide, and severity of asthma in patients with western red cedar asthma. Am J Respir Crit Care Med 1999; 159 : 1434–8.
  35. Gibson PG, Dolovich J, Denburg J, Ramsdale EH. Chronic cough : eosinophilic bronchitis without asthma. Lancet 1989 : 1346–8.
  36. Lemière C, Efthimiadis A, Hargreave FE. Occupational eosinophilic bronchitis without asthma : an unknown occupational airway disease. J Allergy Clin Immunol 1997; 100 : 852–4.
  37. Quirce S, Fernández-Nieto M, de Miguel J, Sastre J. Chronic cough due to latex-induced eosinophilic bronchitis. J Allergy Clin Immunol 2001; 108 : 143.
  38. Krakowiak AM, Dudek W, Ruta U, Palczynski C. Occupational eosinophilic bronchitis without asthma due to chloramine exposure. Occup Med (Lond) 2005; 55 : 396–8.
  39. Quirce S. Eosinophilic bronchitis in the workplace. Curr Opin Allergy Clin Immunol 2004; 4 : 87–91.
  40. Paggiaro PL, Vagaggini B, Bacci E, et al. Prognosis of occupational asthma. Eur Respir J 1994; 7 : 761–7.

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.